Design and synthesis of 3-phenyltetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands. Part II
| Autor: | Daniel Lesieur, Pierre Renard, Philippe Delagrange, Angéline Chanu, Sophie Coumailleau, Caroline Bennejean, Pascal Berthelot, Jean A. Boutin, Christophe Bochu, Saïd Yous, Sophie Durieux, Daniel H. Caignard, Valérie Audinot |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Agonist
Tetrahydronaphthalenes medicine.drug_class Stereochemistry Clinical Biochemistry Cell Culture Techniques Pharmaceutical Science Carboxamide CHO Cells Ligands Transfection Biochemistry Chemical synthesis Partial agonist Cell Line Substrate Specificity Melatonin Structure-Activity Relationship Cricetulus Cricetinae Drug Discovery medicine Animals Structure–activity relationship Receptor Molecular Biology Dose-Response Relationship Drug Receptor Melatonin MT2 Chemistry Organic Chemistry Drug Design Molecular Medicine Selectivity medicine.drug |
| Zdroj: | Bioorganic & Medicinal Chemistry. 17:2963-2974 |
| ISSN: | 0968-0896 |
| DOI: | 10.1016/j.bmc.2009.03.023 |
| Popis: | Following our studies of the melatoninergic receptors, we have developed new tetrahydronaphthalenic derivatives of melatonin that have been tested as selective melatonin receptors ligands. Regarding the role of the phenyl substituent to obtain selective ligands, modulation of selectivity and activity have been achieved by modifications of the acyl group and substitutions on the phenyl ring. Ten of the seventeen evaluated derivatives have MT(2) receptor affinity similar to that of melatonin. Moreover, we have achieved remarkable MT(2) selectivity over MT(1) (selectivity >100) and have been able to further extend the RSA of the tetrahydrophthalenic series. However, the compounds presented here display partial agonist or antagonist behavior instead of full agonist. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect